| Announce Date | 02/05/2026 |
| EPS Normalized Actual | $1.71 (Beat by $0.31) |
| EPS GAAP Actual | $1.71 (Beat by $0.31) |
| Revenue Actual | $3.18142B |
| Revenue Surprise | Beat by $3181.42M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 8.42697 | 27.47 | 8.26474 | 8.59811 | 3 |
| Dec 2028 | 11.52944 | 20.08 | 11.4154 | 11.79025 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.4 | 1.4 | 3.18142B | 6.1% | 3181.42M |
| FQ2 2025 (Jun 2025) | 0.31 | 0.31 | 2.61472B | 20.66% | 2614.72M |
| FQ1 2025 (Mar 2025) | 1.10602 | 1.10602 | 2.80542B | -15.95% | 2805.42M |
| FQ4 2024 (Dec 2024) | 3.93 | 3.93 | 2.88754B | -4.93% | 2887.54M |
| FQ3 2024 (Sep 2024) | 0 | 0 | 2.98749B | 99.92% | 2987.49M |
| FQ2 2024 (Jun 2024) | 0.886 | 0.886 | 2.07448B | -44.02% | 2074.48M |
| FQ1 2024 (Mar 2024) | 3.9 | 3.9 | 3.25275B | 100% | 3252.75M |
| FQ4 2023 (Oct 2023) | 2.6 | 2.6 | 3.02999B | 12.46% | 3029.99M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Sep 2028) | 3.08696 | -- | 2.95191 | 3.20216 | 10 |
| FQ2 2028 (Jun 2028) | 2.31528 | -- | 2.21399 | 2.40169 | 7 |
| FQ1 2028 (Mar 2028) | 2.993 | -- | 2.86206 | 3.1047 | 5 |
| FQ4 2027 (Dec 2027) | 2.0121 | -- | 1.91174 | 2.15043 | 7 |
| FQ3 2027 (Sep 2027) | 2.17482 | -- | 2.06634 | 2.32434 | 7 |
| FQ2 2027 (Jun 2027) | 1.5199 | -- | 1.44409 | 1.62439 | 7 |
| FQ1 2027 (Mar 2027) | 2.13822 | -- | 2.07268 | 2.27363 | 5 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Sep 2028) | 3.49B | -- | 3.37B | 3.59B | 5 |
| FQ2 2028 (Jun 2028) | 2.92B | -- | 2.82B | 3B | 3 |
| FQ1 2028 (Mar 2028) | 3.2B | -- | 3.09B | 3.29B | 3 |
| FQ4 2027 (Dec 2027) | 3.17B | -- | 3.05B | 3.33B | 4 |
| FQ3 2027 (Sep 2027) | 3.38B | -- | 3.25B | 3.56B | 4 |
| FQ2 2027 (Jun 2027) | 2.71B | -- | 2.61B | 2.86B | 4 |
| FQ1 2027 (Mar 2027) | 3.08B | -- | 3.01B | 3.23B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.4 | 1.4 | 100% | |
| FQ2 2025 (Jun 2025) | 0.31 | 0.31 | 100% | |
| FQ1 2025 (Mar 2025) | 1.10602 | 1.10602 | 100% | |
| FQ4 2024 (Dec 2024) | 3.93 | 3.93 | 100% | |
| FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
| FQ2 2024 (Jun 2024) | 0.886 | 0.886 | 100% | |
| FQ1 2024 (Mar 2024) | 3.9 | 3.9 | 100% | |
| FQ4 2023 (Oct 2023) | 2.6 | 2.6 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $3.18B | $3181.42M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $2.61B | $2614.72M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $2.81B | $2805.42M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $2.89B | $2887.54M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $2.99B | $2987.49M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $2.07B | $2074.48M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $3.25B | $3252.75M | 100% |
| FQ4 2023 (Oct 2023) | $0B | $3.03B | $3029.99M | 100% |